Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1991 1
1992 1
1993 2
1994 3
1995 1
1996 1
1997 1
1998 1
1999 4
2000 2
2001 2
2002 9
2004 2
2005 2
2006 2
2007 3
2009 2
2010 1
2011 3
2012 2
2013 1
2014 3
2015 4
2016 5
2017 3
2018 3
2019 3
2020 3
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: lorenzen t. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R; NORD-STAR study group. Hetland ML, et al. Among authors: lorenzen t. BMJ. 2020 Dec 2;371:m4328. doi: 10.1136/bmj.m4328. BMJ. 2020. PMID: 33268527 Free PMC article. Clinical Trial.
[Post-exposure prophylaxis: The earlier the better].
Plettenberg A, Kuhlendahl F, Lorenzen T, Stoehr A. Plettenberg A, et al. Among authors: lorenzen t. MMW Fortschr Med. 2019 Jun;161(Suppl 2):38-42. doi: 10.1007/s15006-019-0578-5. MMW Fortschr Med. 2019. PMID: 31175590 Review. German. No abstract available.
[Diagnosing and treating rheumatoid arthritis].
Iversen DS, Østgård RD, Lorenzen T, Keller KK. Iversen DS, et al. Among authors: lorenzen t. Ugeskr Laeger. 2018 Oct 29;180(44):V06180444. Ugeskr Laeger. 2018. PMID: 30375970 Free article. Danish.
On the pathogenesis of IDDM.
Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T. Nerup J, et al. Among authors: lorenzen t. Diabetologia. 1994 Sep;37 Suppl 2:S82-9. doi: 10.1007/BF00400830. Diabetologia. 1994. PMID: 7821744 Review.
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials.
Tarp S, Furst DE, Dossing A, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez-Almazor ME, Kristensen LE, Bliddal H, Christensen R. Tarp S, et al. Among authors: lorenzen t. Semin Arthritis Rheum. 2017 Jun;46(6):699-708. doi: 10.1016/j.semarthrit.2016.09.003. Epub 2016 Sep 14. Semin Arthritis Rheum. 2017. PMID: 27769592 Review.
Diagnosing patients with longstanding shoulder joint pain.
Nørregaard J, Krogsgaard MR, Lorenzen T, Jensen EM. Nørregaard J, et al. Among authors: lorenzen t. Ann Rheum Dis. 2002 Jul;61(7):646-9. doi: 10.1136/ard.61.7.646. Ann Rheum Dis. 2002. PMID: 12079911 Free PMC article.
Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
Issa SF, Lindegaard HM, Lorenzen T, Junker K, Christensen AF, Hørslev-Petersen K, Holmskov U, Sorensen GL, Junker P. Issa SF, et al. Among authors: lorenzen t. Clin Exp Rheumatol. 2022 Jan;40(1):198. doi: 10.55563/clinexprheumatol/ico144. Epub 2022 Jan 28. Clin Exp Rheumatol. 2022. PMID: 35088690 Free article. No abstract available.
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.
Schäfer VS, Chrysidis S, Dejaco C, Duftner C, Iagnocco A, Bruyn GA, Carrara G, D'Agostino MA, De Miguel E, Diamantopoulos AP, Fredberg U, Hartung W, Hocevar A, Juche A, Kermani TA, Koster MJ, Lorenzen T, Macchioni P, Milchert M, Døhn UM, Mukhtyar C, Ponte C, Ramiro S, Scirè CA, Terslev L, Warrington KJ, Dasgupta B, Schmidt WA. Schäfer VS, et al. Among authors: lorenzen t. J Rheumatol. 2018 Aug;45(9):1289-1295. doi: 10.3899/jrheum.171428. Epub 2018 Jul 1. J Rheumatol. 2018. PMID: 29961687
71 results